Development of exogenous FVIII-specific inhibitor in a mild haemophilia patient with Glu272Lys mutation

Authors

  • J. Yamanouchi,

    Corresponding author
    1. Department of Hematology, Clinical Immunology and Infectious Disease, Ehime University Graduate School of Medicine, Toon, Ehime, Japan
    • Correspondence: Jun Yamanouchi, Department of Hematology, Clinical Immunology and Infectious Disease, Ehime University Graduate School of Medicine, 454 Shitsukawa, Toon, 7910295 Ehime, Japan.

      Tel.: +81 89 960 5296; fax: +81 89 960 5299;

      e-mail: yamanouc@m.ehime-u.ac.jp

    Search for more papers by this author
  • T. Hato,

    1. Division of Blood Transfusion and Cell Therapy, Ehime University Hospital, Toon, Ehime, Japan
    Search for more papers by this author
  • T. Niiya,

    1. Division of Laboratory Medicine, Ehime University Hospital, Toon, Ehime, Japan
    Search for more papers by this author
  • Y. Sato,

    1. Department of Hematology, Clinical Immunology and Infectious Disease, Ehime University Graduate School of Medicine, Toon, Ehime, Japan
    Search for more papers by this author
  • S. Onishi,

    1. Department of Hematology, Clinical Immunology and Infectious Disease, Ehime University Graduate School of Medicine, Toon, Ehime, Japan
    Search for more papers by this author
  • M. Yasukawa

    1. Department of Hematology, Clinical Immunology and Infectious Disease, Ehime University Graduate School of Medicine, Toon, Ehime, Japan
    Search for more papers by this author

Ancillary